Tags

Type your tag names separated by a space and hit enter

Oxidative damage in mild cognitive impairment and early Alzheimer's disease.
J Neurosci Res 2007; 85(14):3036-40JN

Abstract

Increasing evidence supports a role for oxidative damage in the pathogenesis of Alzheimer's disease (AD). Multiple studies show significantly increased levels of lipid peroxidation and protein, DNA, and RNA oxidation in vulnerable regions of the brain of patients with late-stage AD (LAD). More recent studies of patients with amnestic mild cognitive impairment (MCI), the earliest clinical manifestation of AD, show similar patterns of oxidative damage. These observations suggest that oxidative damage to critical biomolecules occurs early in the pathogenesis of AD and precedes pronounced neuropathologic alterations. Because oxidative damage begins early in the progress of the disease, it represents a potential therapeutic target for slowing the onset and progression of AD.

Authors+Show Affiliations

Department of Chemistry, University of Kentucky, Lexington, Kentucky, USA. malove2@uky.eduNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

17510979

Citation

Lovell, Mark A., and William R. Markesbery. "Oxidative Damage in Mild Cognitive Impairment and Early Alzheimer's Disease." Journal of Neuroscience Research, vol. 85, no. 14, 2007, pp. 3036-40.
Lovell MA, Markesbery WR. Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J Neurosci Res. 2007;85(14):3036-40.
Lovell, M. A., & Markesbery, W. R. (2007). Oxidative damage in mild cognitive impairment and early Alzheimer's disease. Journal of Neuroscience Research, 85(14), pp. 3036-40.
Lovell MA, Markesbery WR. Oxidative Damage in Mild Cognitive Impairment and Early Alzheimer's Disease. J Neurosci Res. 2007 Nov 1;85(14):3036-40. PubMed PMID: 17510979.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Oxidative damage in mild cognitive impairment and early Alzheimer's disease. AU - Lovell,Mark A, AU - Markesbery,William R, PY - 2007/5/19/pubmed PY - 2008/2/15/medline PY - 2007/5/19/entrez SP - 3036 EP - 40 JF - Journal of neuroscience research JO - J. Neurosci. Res. VL - 85 IS - 14 N2 - Increasing evidence supports a role for oxidative damage in the pathogenesis of Alzheimer's disease (AD). Multiple studies show significantly increased levels of lipid peroxidation and protein, DNA, and RNA oxidation in vulnerable regions of the brain of patients with late-stage AD (LAD). More recent studies of patients with amnestic mild cognitive impairment (MCI), the earliest clinical manifestation of AD, show similar patterns of oxidative damage. These observations suggest that oxidative damage to critical biomolecules occurs early in the pathogenesis of AD and precedes pronounced neuropathologic alterations. Because oxidative damage begins early in the progress of the disease, it represents a potential therapeutic target for slowing the onset and progression of AD. SN - 0360-4012 UR - https://www.unboundmedicine.com/medline/citation/17510979/Oxidative_damage_in_mild_cognitive_impairment_and_early_Alzheimer's_disease_ L2 - https://doi.org/10.1002/jnr.21346 DB - PRIME DP - Unbound Medicine ER -